A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

The company said in a release last month about a human clinical trial that it is “a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating ...

“By identifying opportunities to bring in stable revenue, we believe the Company can reduce its need for capital that could be dilutive to the stock price,” Latkin said. The real estate ...

A nonprofit incubator said it will take over a 33,000-square-foot building in Richmond, which also possesses manufacturing ...

Windtree Therapeutics' CEO explains the strategy behind the biotech company's surprising $43 million apartment complex acquisition. Bucks County biotech firm hires investment bank to explore M&A ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

With its proven GlobalReady program and agile biotech-focused model, Avance Clinical enables emerging biopharma companies to achieve accelerated development timelines, backed by world-class data ...

For deeper insights into how management changes impact biotech companies, InvestingPro subscribers can access exclusive ProTips and comprehensive analysis tools. Stuart Duty, with over 30 years of ...

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...